| Deal value | $7.0B |
|---|---|
| Share of market cap | 19.3% |
| Share of annual revenue | 42.6% |
Key highlights
- Expiration extended from October 27 to November 2, 2026
- Exchange involves seven series of notes with maturities ranging from 2028 to 2063
- Highest participation noted in 2053 notes with 98.54% of principal already tendered
- Settlement is strictly conditioned on the consummation of the Kenvue acquisition
- Requisite consents to amend Kenvue indentures were successfully secured on October 9, 2026
What Is the Deal?
Kimberly-Clark is pursuing the acquisition of Kenvue Inc., the consumer health business formerly part of Johnson & Johnson, in a transaction valued at approximately $48.7 billion. The consideration involves a mix of cash and stock, intended to combine Kimberly-Clark’s personal care portfolio with Kenvue’s diverse health brands. To facilitate the merger, Kimberly-Clark has initiated a private exchange offer for $7.0 billion of Kenvue’s outstanding senior notes. The latest extension moves the expiration date to November 2, 2026, allowing more time for the final settlement of these financial instruments as the companies work toward the deal's closing.
Deal Structure & Terms
- Offer involves exchanging outstanding Kenvue notes for new senior unsecured notes issued by Kimberly-Clark
- Debt tiers include 5.050% notes due 2028 up to 5.200% notes maturing in 2063
- Tendered amounts as of October 27 include $1.48 billion of the 2053 notes and $1.15 billion of the 2033 series
- Acquisition financing includes a separate $4.9 billion senior unsecured notes offering scheduled to close October 29, 2026
- Amendments to the Kenvue indenture will only become operative upon the final settlement of the exchange offers
Strategic Rationale
The acquisition represents a transformative shift for Kimberly-Clark, aiming to scale its global footprint in the consumer defensive sector. By integrating Kenvue, Kimberly-Clark gains access to high-margin consumer health categories that complement its existing brands like Huggies and Kleenex. This move follows a strategic streamlining of its portfolio, including the June 2025 divestiture of a 51% stake in its International Family Care and Professional business for $1.73 billion. Management has indicated that the merger is expected to drive long-term growth, supporting recent guidance for mid-single-digit operating profit growth on a constant-currency basis for the 2026 fiscal year.
Financial Context
Kimberly-Clark maintains a robust financial profile with annual revenue of $16,447 million and a market capitalization of $36.3 billion. The $48.7 billion Kenvue acquisition represents a significant expansion relative to Kimberly-Clark's existing balance sheet. This expansion is supported by a debt strategy that includes a $4.9 billion senior notes offering. Current technical indicators show the stock trading with an RSI of 64.2, following a 10.84% monthly price increase. The company recently reaffirmed its full-year 2026 guidance, targeting high single-digit growth in adjusted earnings per share from continuing operations despite ongoing global market volatility.
Up 2.1% since our story on 28 Oct: $109.10 when we broke it → $111.34 at the close on 16 Nov. Daily closing prices. Source: Yahoo Finance.
Show the prices
| 19 Oct | $105.41 |
|---|---|
| 20 Oct | $108.33 |
| 21 Oct | $106.64 |
| 22 Oct | $112.32 |
| 23 Oct | $110.15 |
| 26 Oct | $109.63 |
| 27 Oct | $109.10 |
| 28 Oct | $108.40 |
| 29 Oct | $110.02 |
| 30 Oct | $107.94 |
| 2 Nov | $108.25 |
| 3 Nov | $104.46 |
| 4 Nov | $108.79 |
| 5 Nov | $110.46 |
| 6 Nov | $108.43 |
| 9 Nov | $111.93 |
| 10 Nov | $110.76 |
| 11 Nov | $108.86 |
| 12 Nov | $107.19 |
| 13 Nov | $109.43 |
| 16 Nov | $111.34 |
Industry Landscape
The consumer packaged goods sector is currently undergoing a period of consolidation as legacy firms seek to offset inflationary pressures through increased scale and portfolio premiumization. M&A activity in the household and personal products industry has focused on high-growth segments like dermatology and specialized health, mirroring Kimberly-Clark's pursuit of Kenvue. This trend is occurring alongside a broader focus on operational efficiency; for instance, Kimberly-Clark recently reported preliminary third-quarter net sales of $4,134 million. Large-cap players are increasingly utilizing debt exchange offers to optimize capital structures following major acquisitions, ensuring liquidity remains stable while integrating multi-billion dollar targets.
| Date | Announcement | Amount |
|---|---|---|
| 03 Nov 2025 | Acquisition of Kenvue Inc. in a cash-and-stock transactionSource: metissue.com | $48.70 Billion |
| 05 Jun 2025 | Divestiture of 51% stake in International Family Care and Professional (IFP) business to Suzano S.A.Source: investor.kimberly-clark.com | $1.73 Billion |
| Share price | $109.10 |
|---|---|
| Market cap | $36.3B |
| Revenue (annual) | $16.4B |
| P/E (TTM) | 21.5× |
| 1-month price change | +10.84% |
| Sector | Consumer DefensiveHousehold & Personal Products |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
SEC filing by Kimberly-Clark Corporation announcing an extension of its $7 billion debt exchange offer for Kenvue Inc. notes.
Track KIMBERLY CLARK CORP live
Get the next KIMBERLY CLARK CORP SEC filing seconds after it lands.




